Interestingly, one recurrent intergenic FGFR2 fusion was identified solely in patients with gastric cancer (6/22, 27.3%), being fused to intergenic regions upstream of WDR11. Similar to FGFR3, the majority of FGFR2 breakpoints were located in intron 17. Here, FGFR3 is linked to gastric cancer.